A director at Avantium N.V. sold 14,880 shares at 10.130EUR and the significance rating of the trade was 65/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...
Air France-KLM was back into the bond market last week through the issuance of a € 500m 5Y bond priced at MS+155bps (i.e. a yield of 3.85%), which is at the lower end of the price guidance (MS+155-160bps) and tighter than the IPT (MS+190bps). Proceeds from the transaction will be used for general corporate purposes, with no further information provided. We understand that this will be used to refinance upcoming debt including the CB/Perpetual (if not converted) or the 2026 maturities. The timing...
Air France-KLM was back into the bond market last week through the issuance of a € 500m 5Y bond priced at MS+155bps (i.e. a yield of 3.85%), which is at the lower end of the price guidance (MS+155-160bps) and tighter than the IPT (MS+190bps). Proceeds from the transaction will be used for general corporate purposes, with no further information provided. We understand that this will be used to refinance upcoming debt including the CB/Perpetual (if not converted) or the 2026 maturities. The timing...
Ackermans & van Haaren: A strong 1H25. Avantium: Nearly there. Eurocommercial Properties: Good results, positive effects of remerchandising. Recticel: Weak 1H25 calls for a 12% downgrade to consensus at Adj. EBITDA level. Sif Group: 2025 and 2026 guidance cuts. Staffing: Belgium - July Temp volume weaker at -3.5% YoY despite easier comps
CROSSJECT : Information relative au nombre total de droits de vote et d'actions composant le capital social Communiqué de Presse Information relative au nombre total de droits de vote et d’actions composant le capital social Dijon, le 27 aout 2025 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui développe et commercialisera prochainement un portefeuille de médicaments dédiés aux situations d’urgence, publie conformément aux articles 223-16 du Règlement général de l’AMF et L.233-8 II du Code de commerce, le nombre total de droits de vote et d’actions composant so...
CROSSJECT : Information relative au nombre total de droits de vote et d'actions composant le capital social Communiqué de Presse Information relative au nombre total de droits de vote et d’actions composant le capital social Dijon, le 27 aout 2025 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui développe et commercialisera prochainement un portefeuille de médicaments dédiés aux situations d’urgence, publie conformément aux articles 223-16 du Règlement général de l’AMF et L.233-8 II du Code de commerce, le nombre total de droits de vote et d’actions composant so...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.